Kalliovalkama J, Kähönen M, Tolvanen J P, Wu X, Voipio J, Pekki A, Doris P A, Ylitalo P, Pörsti I
Department of Pharmacological Sciences, University of Tampere, Finland.
Pharmacol Toxicol. 2000 Jan;86(1):36-43. doi: 10.1034/j.1600-0773.2000.pto860107.x.
Treatment with the angiotensin-converting enzyme inhibitor, quinapril, has been shown to normalize increased dihydropyridine sensitivity and impaired potassium relaxation, characteristic features of arterial smooth muscle in spontaneously hypertensive rats, and also reduce the concentration of plasma digoxin-like immunoreactivity in these animals. However, whether angiotensin II receptor blocker therapy can beneficially influence these variables is not known. Therefore, we compared the effects of 10-week losartan and enalapril treatments (15 and 4 mg/kg/day, respectively) on functional responses of mesenteric arterial rings in spontaneously hypertensive rats and Wistar-Kyoto rats. Both losartan and enalapril normalized blood pressure, cardiac mass, and media to lumen ratio without significantly changing the media cross-sectional area in the mesenteric artery of spontaneously hypertensive rats (i.e. induced outward remodelling). The inhibitory effect of the calcium entry blocker nifedipine on calcium-evoked contractions was similar and less marked in arterial preparations from Wistar-Kyoto rats and losartan- and enalapril-treated spontaneously hypertensive rats than in those from untreated spontaneously hypertensive rats. Furthermore, the relaxations of arterial rings induced by the return of potassium to the organ bath (upon precontractions elicited by potassium-free solution) were used to evaluate the function of vascular Na+,K+-ATPase. The rate of potassium relaxation was faster in losartan- and enalapril-treated spontaneously hypertensive rats and all Wistar-Kyoto groups than in untreated spontaneously hypertensive rats, and the response was effectively inhibited by the sodium pump inhibitor ouabain. Both treatments especially augmented the ouabain-sensitive part of the potassium-relaxation in spontaneously hypertensive rats, indicating the involvement of the sodium pump in this response. However, no significant changes in plasma digoxin-like immunoreactivity were observed. In conclusion, the outward remodelling following long-term AT1-receptor blockade and angiotensin-converting enzyme inhibition in spontaneously hypertensive rats was associated with normalization of the increased dihydropyridine sensitivity of arteries. Both losartan and enalapril treatments also augmented arterial potassium relaxation in spontaneously hypertensive rats, suggesting enhanced function of Na+,K+-ATPase, but this effect could not be attributed to changes in circulating sodium pump inhibitor concentration.
血管紧张素转换酶抑制剂喹那普利治疗已显示可使自发性高血压大鼠动脉平滑肌的特征性改变——二氢吡啶敏感性增加和钾诱导舒张功能受损恢复正常,并且还可降低这些动物血浆中地高辛样免疫反应物的浓度。然而,血管紧张素II受体阻滞剂治疗是否能有益地影响这些变量尚不清楚。因此,我们比较了10周氯沙坦和依那普利治疗(分别为15和4mg/kg/天)对自发性高血压大鼠和Wistar-Kyoto大鼠肠系膜动脉环功能反应的影响。氯沙坦和依那普利均可使自发性高血压大鼠的血压、心脏重量以及中膜与管腔比值恢复正常,而未显著改变肠系膜动脉的中膜横截面积(即诱导外向重塑)。钙通道阻滞剂硝苯地平对钙诱发收缩的抑制作用在Wistar-Kyoto大鼠以及氯沙坦和依那普利治疗的自发性高血压大鼠的动脉标本中相似且较未治疗的自发性高血压大鼠的标本中作用更不明显。此外,通过将钾离子重新加入器官浴液(在无钾溶液诱发预收缩后)诱导的动脉环舒张来评估血管Na+,K+-ATP酶的功能。氯沙坦和依那普利治疗的自发性高血压大鼠以及所有Wistar-Kyoto组的钾离子舒张速率均比未治疗的自发性高血压大鼠更快,并且该反应可被钠泵抑制剂哇巴因有效抑制。两种治疗尤其增强了自发性高血压大鼠钾离子舒张中对哇巴因敏感的部分,表明钠泵参与了该反应。然而,未观察到血浆中地高辛样免疫反应物有显著变化。总之,自发性高血压大鼠长期AT1受体阻断和血管紧张素转换酶抑制后的外向重塑与动脉中二氢吡啶敏感性增加的正常化相关。氯沙坦和依那普利治疗还增强了自发性高血压大鼠的动脉钾离子舒张,提示Na+,K+-ATP酶功能增强,但该作用不能归因于循环中钠泵抑制剂浓度的变化。